NanoViricides, Inc. (OTC BB: NNVC.OB)

Turning Pennies into dollars: NanoViricides, Inc. (OTC BB: NNVC.OB)

Are you a public company looking for exposure?

Contact RealPennies.com - 212-662-2147



For more info: http://www.realpennies.com/otc/nnvc

Monday April 6, 2009, 7:00 am EDT

NanoViricides, Inc. (OTC BB: NNVC.OB) (the "Company"), is providing a summary of its achievements over the past 12 months.

Most significantly, the Company reported in June, 2008, that animals treated with its anti-HIV lead drug candidate exhibited survival time superior to that of animals treated with the standard three drug oral cocktail called HAART. These studies employed the well established SCID-Hu Thy/Liv mouse model and were conducted by KARD Scientific, Inc. The Company plans to perform additional studies to obtain further detailed information regarding the effect of the nanoviricide drug candidates on HIV in vivo.

NanoViricides, Inc. has reported in May, 2008, that its anti-EKC (epidemic keratoconjunctivitis) drug candidate exhibited excellent clinical improvement in an ophthalmic adenovirus infection animal model of this disease. These studies were conducted by scientists at the Feinstein Institute of Medical Research (FIMR), part of the North Shore-LIJ Health System. These studies were presented by the FIMR scientists at the 42nd annual meeting of the Ocular Microbiology and Immunology Group (OMIG) in Atlanta, Georgia, in November 2008. In addition, evaluation of our ophthalmic anti-herpes nanoviricide drug candidates will begin shortly at a renowned School of Veterinary Medicine in the US.

The Company further reports satisfactory progress in its anti-Rabies program. These studies are continuing at the US Centers for Diseases Control and Prevention (CDC).

The Company is presently in discussions with an independent research facility to perform anti-H5N1 animal studies with the Company’s drug candidates that were highly successful against H5N1 Clade 1 and Clade 2 in cell cultures. These nanoviricides were also found to be highly effective against common influenza (H1N1) in animal models.

The Company has previously reported positive results for its Ebola program. The first part of the program consisted of cell culture studies of the effect of nanoviricides against Ebola virus. Several nanoviricide drug candidates showed very high efficacy against Ebola in these studies. These studies were conducted by scientists at the United States Army Medical Research Institute for Infectious Diseases (USAMRIID). Subsequently, the Company was invited to submit a grant application to the TMTI program of the Department of Defense (DoD) and did so this January. The objective of the grant application is to further develop both the Ebola and Dengue programs of the Company. The DoD is interested in further development of our broad-spectrum nanoviricides in order to minimize stockpiling costs while still achieving high efficacies against a broad range of viruses.

The Company previously reported that it has signed certain agreements regarding further development of its eye drug candidate. In addition, several other potential collaboration partners have expressed a strong interest in pursuing co-development opportunities for the Company’s other drug candidates. The Company is actively pursuing these opportunities.

“We have attained strong positive achievements in the past twelve months in all of our drug development programs,” said Eugene Seymour, MD, MPH, CEO of the Company, adding, “We are confident that we will achieve further successes in our drug development and commercialization programs during the next calendar year as well.”

About NanoViricides:

NanoViricides, Inc. (www.nanoviricides.com) is a development stage company that is creating special purpose nanomaterials for viral therapy. The Company's novel nanoviricide™ class of drug candidates are designed to specifically attack enveloped virus particles and to dismantle them. The Company is developing drugs against a number of viral diseases including H5N1 bird flu, seasonal Influenza, HIV, EKC, Hepatitis C, Rabies, Dengue fever, and Ebola virus, among others.

This press release contains forward-looking statements that reflect the Company's current expectation regarding future events. Actual events could differ materially and substantially from those projected herein and depend on a number of factors. Certain statements in this release, and other written or oral statements made by NanoViricides, Inc. are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond the Company's control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. The Company assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. Important factors that could cause actual results to differ materially from the company's expectations include, but are not limited to, those factors that are disclosed under the heading "Risk Factors" and elsewhere in documents filed by the company from time to time with the United States Securities and Exchange Commission and other regulatory authorities. Although it is not possible to predict or identify all such factors, they may include the following: demonstration and proof of principle in pre-clinical trials that a nanoviricide is safe and effective; successful development of our product candidates; our ability to seek and obtain regulatory approvals, including with respect to the indications we are seeking; the successful commercialization of our product candidates; and market acceptance of our products.



Realpennies.com



Investors are advised that this analysis is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy. This report does not have regard to the specific investment objectives, financial situation and the particular needs of any specific person who may receive this information. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Past performance is no guarantee of future results. Please consult a broker before purchasing or selling any securities mentioned on http://www.realpennies.com/start.html

Any opinions expressed herein are statements of our judgment as of the date of publication and are subject to change without notice. This may contain forward-looking statements and are not guarantees of performance. Reproduction of this without written permission is prohibited.

RealPennies.com

Phone: 212-662-2147

info [at] realpennies.com

 

 

CTD Holdings, Inc. (OTC BB:CTDH.OB)

Turning Pennies into dollars: CTD Holdings, Inc. (OTC BB:CTDH.OB)

Are you a public company looking for exposure?

Contact RealPennies.com - 212-662-2147



For more info: http://www.realpennies.com/otc/ctdh

Apr 6, 2009 - CTD Holdings, Inc. (OTC BB:CTDH.OB) announcedrecently that the Board of Directors has invited and approvedLouis S. Weltmanto serve on the Company's Board of Directors.

Mr. Weltman is President of JLW Management Corp., a realestate developmentand financing company based in Boca Raton. Mr. Weltman,a graduate from theUniversity of Pennsylvania's Wharton School, has establisheda career inmerchant banking, business and real estate development,focusing oncorporate strategy, consulting and capital restructuring.

"We are pleased that Mr. Weltman has accepted our invitationto join ourBoard of Directors. Mr. Fails and I believe that based onMr. Weltman'sbackground, he complements the current board in its effortsto create thenew research park; his expertise in real estate developmentas well asinvestment banking is greatly needed," stated Mr. Strattan,CEO/Chairman."With Mr. Weltman's assistance, we have already identifiedstrategicopportunities for the Company which, we believe, will enhancethevisibility of the Company in our core industry, and createadditionalsources of revenue and profits for the Company."

About CTD Holdings, Inc.

The company is the one-stop shop, business to business facilitatorofcommercial applications of cyclodextrins. With its brandedTrappsol® andAquaplex® product offerings, CTDH scientists coordinatethe developmentof commercial products for use in the pharmaceuticals, foods,hazardouswaste treatment, and cosmetics industries, just to namea few of theindustries which endeavor to put non water-soluble ingredientsintowater-based formulations. CTDH was founded in 1990 as aFlorida corporationand became a public company in 1994. Additional informationon the Companycan be found on the Company's website: www.cyclodex.com

This news release contains "forward-looking statements"that are madepursuant to the safe harbor provisions of the Private SecuritiesLitigationReform Act of 1995. You are cautioned that such statementsare subject torisks and uncertainties that could cause future circumstances,events orresults to differ materially from those projected in theforward-lookingstatements. CTDH complies with the regulations and timelines mandated bythe SEC in the filing of its financial reports; these filingsalso containforward-looking statements. The above forward-looking statementsare madeas of the date above; CTD Holdings, Inc. accepts no specificresponsibilityfor updating such statements.



Realpennies.com



Investors are advised that this analysis is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy. This report does not have regard to the specific investment objectives, financial situation and the particular needs of any specific person who may receive this information. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Past performance is no guarantee of future results. Please consult a broker before purchasing or selling any securities mentioned on http://www.realpennies.com/start.html

Any opinions expressed herein are statements of our judgment as of the date of publication and are subject to change without notice. This may contain forward-looking statements and are not guarantees of performance. Reproduction of this without written permission is prohibited.

RealPennies.com

Phone: 212-662-2147

info [at] realpennies.com

 

 

Patriot Scientific Corporation (OTC Bulletin Board: PTSC)

Turning Pennies into dollars: Patriot Scientific Corporation (OTC Bulletin Board: PTSC)

Are you a public company looking for exposure?

Contact RealPennies.com - 212-662-2147



For more info: http://www.realpennies.com/otc/ptsc

Patriot Scientific Corporation (OTC Bulletin Board: PTSC) announces the following Webcast:

What:     Patriot Scientific Corporation FY09Q3 Shareholder Call   

When:     April 14, 2009 @ 4:30 p.m. EST   

Where:    http://www.videonewswire.com/event.asp?id=57493   

How:      Live over the Internet -- Simply log on to the web at the              address above.   

Contact:  Angela Hartley, Investor Relations at Patriot Scientific              Corporation, 760 547 2700 x102

To listen to the live webcast, please go to this website approximately fifteen minutes prior to the start of the call to register, download and install any necessary audio software. If you are unable to participate during the live webcast, the call will be archived on the Investor page of the Patriot website http://www.ptsc.com/ for thirty days.

To participate in the conference call by telephone, please call 800-860-2442 (toll free in the U.S.) or 412-858-4600 (toll call outside the U.S.) and request the "Patriot Scientific" conference call.

Headquartered in Carlsbad, California, Patriot Scientific Corporation provides data sharing and secure data solutions for a connected world. Patriot Scientific has recently embarked on an aggressive business expansion initiative complementing its recent acquisition of data sharing software provider, Crossflo Systems Inc. Patriot is evaluating full M&A and minority investments in early-stage technology companies in the data sharing software and secure networking technology sectors. These investments are funded with revenues generated, in a large part, from the continuing successful Moore Microprocessor Patent(TM) Portfolio licensing partnership with The TPL Group. Patriot Scientific's integrated core intelligence solution addresses the critical data/information sharing needs of the healthcare industry, the Department of Homeland Security, the Department of Justice, and federal, state, and local public safety and law enforcement agencies. For more information on Patriot Scientific Corporation, visit: www.ptsc.com.



Realpennies.com



Investors are advised that this analysis is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy. This report does not have regard to the specific investment objectives, financial situation and the particular needs of any specific person who may receive this information. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Past performance is no guarantee of future results. Please consult a broker before purchasing or selling any securities mentioned on http://www.realpennies.com/start.html

Any opinions expressed herein are statements of our judgment as of the date of publication and are subject to change without notice. This may contain forward-looking statements and are not guarantees of performance. Reproduction of this without written permission is prohibited.

RealPennies.com

Phone: 212-662-2147

info [at] realpennies.com

 

 

BioSolar, Inc. (OTCBB:BSRC)

Turning Pennies into dollars: BioSolar, Inc. (OTCBB:BSRC)

Are you a public company looking for exposure?

Contact RealPennies.com - 212-662-2147



For more info: http://www.realpennies.com/otc/bsrc

BioSolar, Inc. (OTCBB:BSRC) announced recently that it will exhibit its BioBacksheet™ solar cell technology at the International Green Energy Expo, and event organized by EXCO, The Korea Energy News, expected to draw more than 30,000 visitors from over 17 countries April 8-10 at the Daegu Exhibition & Convention Center in Korea. The company’s BioBacksheet™ protective covering for photovoltaic solar cells replaces expensive and potentially hazardous petroleum-based film with renewable biobased materials, creating a more environmentally-friendly and cost-effective solar panel component expected to be instrumental in driving down the cost per watt of photovoltaic solar power.

“We have successfully demonstrated that functional photovoltaic backsheets can be produced from sustainable resources. Our bio-based materials – both individually and in combination – meet or exceed the characteristics of various testing and performance standards for the photovoltaic industry,” said David Lee, BioSolar’s chairman and CEO.

“The BioBacksheet™ will not only reduce the costs associated with photovoltaic modules, but also make a global contribution to a source of true green energy,” said K. M. Suh, president of Shin Ha, Inc., BioSolar’s new Korean marketing partner. “BioSolar’s innovative use of sustainable and recyclable natural resources will undoubtedly be adopted into PV modules by leading manufacturers throughout Korea and globally.”

Designed to replace existing petroleum-based backsheets for silicon (c-Si) photovoltaic solar panels, the first commercially available BioBacksheet™ is a highly water resistant and high dielectric strength bio-based material combined with cellulosic film. Ongoing expansion of the patent-pending BioBacksheet™ technology is also expected to accommodate copper-indium-gallium-selenide (CIGS) and cadmium telluride (CdTe) thin-film photovoltaic panels.

“Solar power produces clean energy, but in order for it to be considered truly sustainable, we need to ensure we are environmentally sensitive in the production and disposal process as well,” said Lee. “Whether solar cells are produced using crystalline silicon, amorphous silicon or other solar technologies, BioSolar can help reduce the cost per watt through the use of its lower cost bio-based materials by removing petroleum from solar cells, making solar energy a true green source of energy.”

About BioSolar, Inc.

BioSolar, Inc. has developed a breakthrough technology to produce bio-based materials from renewable plant sources that will reduce the cost per watt of solar cells. Most of the solar industry is focused on photovoltaic efficiency to reduce cost. BioSolar is the first company to introduce a new dimension of cost reduction by replacing petroleum-based plastic solar cell components with durable bio-based materials. To learn more about BioSolar, please visit our website at http://www.biosolar.com.

Safe Harbor Statement

Matters discussed in this press release contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. When used in this press release, the words "anticipate," "believe," "estimate," "may," "intend," "expect" and similar expressions identify such forward-looking statements. Actual results, performance or achievements could differ materially from those contemplated, expressed or implied by the forward-looking statements contained herein. These forward-looking statements are based largely on the expectations of the Company and are subject to a number of risks and uncertainties. These include, but are not limited to, risks and uncertainties associated with: the impact of economic, competitive and other factors affecting the Company and its operations, markets, product, and distributor performance, the impact on the national and local economies resulting from terrorist actions, and U.S. actions subsequently; and other factors detailed in reports filed by the Company.



Realpennies.com



Investors are advised that this analysis is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy. This report does not have regard to the specific investment objectives, financial situation and the particular needs of any specific person who may receive this information. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Past performance is no guarantee of future results. Please consult a broker before purchasing or selling any securities mentioned on http://www.realpennies.com/start.html

Any opinions expressed herein are statements of our judgment as of the date of publication and are subject to change without notice. This may contain forward-looking statements and are not guarantees of performance. Reproduction of this without written permission is prohibited.

RealPennies.com

Phone: 212-662-2147

info [at] realpennies.com

 

 

Air Water International Corporation(AWTI)

Turning Pennies into dollars: Air Water International Corporation(AWTI)

Are you a public company looking for exposure?

Contact RealPennies.com - 212-662-2147



For more info: http://www.realpennies.com/otc/awti

Apr 6, 2009 - Air Water International Corporation(Other OTC:AWTI.PK) subsidiary Air Water Corporation CEO,Michael Zwebner,stated recently that the company continues to develop new enhancedtechnologyfor use in all its large air to water machines that areset to improvewater production by some 20%. In addition, the new largemachines will alsohave a more efficient production of water, giving the endusers fasteraccess to the drinking water needed.

In a statement issued in Miami recently, he said: "Our recentsales andcomments back from customers has shown us the need to improvethe waterproduction and reduce the energy consumption, so we continueto work toimprove the existing technology and implement the new developmentsinto ourmachines thus increasing their efficiency all the time.More water for lesspower is our company's mission, which we strive to perfect.All our newlarge machines will be made with this new generation ofWater Rushtechnology, for no increase in price. So effectively, allour currentprices are discounted by 20% in terms of cost of increasedwaterproduction.

"Air Water Corporation is leading the world in this excitingnew innovativewater delivery technology, and thus changing the lives ofthe waterrecipients permanently."

About Air Water Corporation

Air Water Corporation designs and manufactures a wide rangeof air to watermachines and systems that can offer consumers from 25 litersto over 5,000liters of pure filtered drinking water daily. The companymanufactures themachines in several global manufacturing locations, andmarkets anddistributes the entire range of its machines and systemson a worldwidebasis. For further information visit our web address:http://www.airwatercorp.com

About Air Water International Corporation

For more information visit the Air Water International Corporationwebsiteat www.airwaterinternational.com

Safe Harbor Statement

Caution Concerning Forward-Looking Statements by Air WaterInternationalCorporation. This document includes certain forward-lookingstatementswithin the meaning of the Private Securities LitigationReform Act of 1995.These statements are based on management's current expectationsor beliefs,and are subject to uncertainty and changes in circumstances.Actual resultsmay vary materially from those expressed or implied by thestatementsherein due to changes in economic, business, competitive,technologicaland/or regulatory factors, and factors affecting the integrationof thebusinesses of Air Water International Corporation. Moredetailedinformation about these factors may be found in filingsby Air WaterInternational Corporation with the Securities and ExchangeCommission,including their most recent annual reports on Form 10-KSBand quarterlyreports on Form 10-QSB. Air Water International Corporationis under noobligation to, and expressly disclaims any such obligationto, update oralter their forward-looking statements, whether as a resultof newinformation, future events, or otherwise.



Realpennies.com



Investors are advised that this analysis is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy. This report does not have regard to the specific investment objectives, financial situation and the particular needs of any specific person who may receive this information. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Past performance is no guarantee of future results. Please consult a broker before purchasing or selling any securities mentioned on http://www.realpennies.com/start.html

Any opinions expressed herein are statements of our judgment as of the date of publication and are subject to change without notice. This may contain forward-looking statements and are not guarantees of performance. Reproduction of this without written permission is prohibited.

RealPennies.com

Phone: 212-662-2147

info [at] realpennies.com

 

 

Cord Blood America, Inc. (OTC Bulletin Board: CBAI)

Turning Pennies into dollars: Cord Blood America, Inc. (OTC Bulletin Board: CBAI)

Are you a public company looking for exposure?

Contact RealPennies.com - 212-662-2147



For more info: http://www.realpennies.com/otc/cbai

Monday April 6, 2009, 6:00 am EDT

Cord Blood America, Inc. (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company (http://www.cordblood-america.com ) focused on bringing the life saving potential of stem cells to families nationwide and internationally, recently announced that between February 15, 2009, and recently, it has reduced its long term debt by approximately $750,000, or 12 percent. This follows the announcement on Feb. 12, 2009 that long term debt had been reduced by $1 million from Jan. 1, 2009 until Feb. 12.

The Company previously said in press releases and CEO interviews that a major focus is to reduce debt and strengthen the Cord Blood America balance sheet. Cord Blood America said the effort to further reduce debt will continue throughout 2009.

CEO Matthew Schissler commented: "De-levering our balance sheet coupled with strategic growth and acquisitions are the primary goals for 2009. I'm certain shareholders would agree that removing debts and structuring a healthy balance sheet will help put the Company in a strong position for long term growth in the stem cell industry."

About Cord Blood America

Cord Blood America (OTC Bulletin Board: CBAI) is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders. To find out more about Cord Blood America, Inc. (OTC Bulletin Board: CBAI), visit our website at www.corcell.com. For investor information, visit www.cordblood-america.com.



Realpennies.com



Investors are advised that this analysis is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy. This report does not have regard to the specific investment objectives, financial situation and the particular needs of any specific person who may receive this information. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Past performance is no guarantee of future results. Please consult a broker before purchasing or selling any securities mentioned on http://www.realpennies.com/start.html

Any opinions expressed herein are statements of our judgment as of the date of publication and are subject to change without notice. This may contain forward-looking statements and are not guarantees of performance. Reproduction of this without written permission is prohibited.

RealPennies.com

Phone: 212-662-2147

info [at] realpennies.com

 

 

Sparrowtech Resources Inc. (OTCBB:SPMC.PK)

Turning Pennies into dollars: Sparrowtech Resources Inc. (OTCBB:SPMC.PK)

Are you a public company looking for exposure?

Contact RealPennies.com - 212-662-2147



For more info: http://www.realpennies.com/otc/spmc

Sparrowtech Releases Eagle Nest Property Details

Monday April 6, 2009, 8:00 am EDT

Sparrowtech Resources Inc. (OTCBB:SPMC.PK) recently announced details on the Eagle Nest Mining Property (“Eagle Nest”) located in La Paz County, Arizona. The Company recently entered into an agreement to acquire 100% ownership of Eagle Nest from D.A.R Mining. The acquisition is expected to close in May 2009 providing management is satisfied that this agreement is in the best interest of its shareholders and sufficient financing has been secured.

President Cornelia Volino stated, "Sparrowtech's corporate mission is to establish itself as a leader of environmentally conscious mining operations. We feel the acquisition of Eagle Nest is a remarkable opportunity and huge leap forward for the Company.” She further stated, “Eagle Nest is located in an area with many historically prolific mines and has an excellent opportunity to potentially produce millions of tons of head ore. We look forward to presenting the results from independent assay and concentration tests on Eagle Nest shortly.”

The Eagle Nest Mining Property

Mineralization previously documented on Eagle Nest is very fine-grained to visible flaky gold, with oxidized copper ores and staining, in a linear, lenticular ore body with a steeply dipping fault zone cutting metamorphic Mesozoic, red, hematitic shale. Lenticular ore body formed from oxidation and enrichment was also found in the fault zone.

Previous workings include a 400 feet (121.92 meter) deep shaft and about 170 feet of drifts on the 100 level with some near-surface stopes. The previous mining operation on this property recorded historic productions of 1,050 tons of ore averaging about 1.07 ounces per ton gold, 1.8% copper and 2.1 ounces per ton silver. Eagle Nest claims include a previously producing Au-Cu-Ag-Fe (Gold, Copper, Silver and Iron) mine.

History of the Bouse Mining District

The Bouse Mining District, where Eagle Nest is located, is a mid-tertiary system of epithermal mineralization, which was introduced into a stacked sequence of lithotectonic units that are located on the northern side of the Plomosa Detachment Fault. Complex epithermal gold, barite and fluorite mineralization is superimposed on earlier copper-specularite mineralization. Gold occurs in laterally extensive breccias and in steeply dipping amethystine-quartz veins. These deposits are similar to the proven and mined Copperstone and Mesquite deposits.

This District involves an important type of Arizona gold deposit, called a "detachment fault" deposit. Detachment fault deposits were first recognized as a separate form of gold deposit in the 1980's. The best example of an Arizona detachment gold deposit is Copperstone, which is about 20 miles from Bouse. It was the biggest gold discovery in Arizona in at least 50 years. Cyprus Gold profitably mined the 500,000 oz open pit resource during the 1980's. The Bouse Mining District is an historic gold producer.

About Sparrowtech Resources, Inc.

Sparrowtech Resources, Inc. is an exploration and resource development company focused on acquiring environmentally conscious mining operations, primarily in North America. The Company's leadership team plans to identify unique opportunities to extract gold and other precious metals from previously producing mines and/or establish new discoveries in recognized gold districts. The Company's strategy follows socially responsible production by supporting improved working conditions and modernization techniques that leave little to no carbon footprint. For more information, visit www.sparrowtech.net

Safe Harbor

This press release contains statements, which may constitute "forward-looking statements" within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Those statements include statements regarding the intent, belief or current expectations of Sparrowtech Resources, Inc., and members of its management as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. Important factors currently known to management that could cause actual results to differ materially from those in forward-statements include fluctuation of operating results, the ability to compete successfully and the ability to complete before-mentioned transactions. The company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results.



Realpennies.com



Investors are advised that this analysis is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy. This report does not have regard to the specific investment objectives, financial situation and the particular needs of any specific person who may receive this information. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Past performance is no guarantee of future results. Please consult a broker before purchasing or selling any securities mentioned on http://www.realpennies.com/start.html

Any opinions expressed herein are statements of our judgment as of the date of publication and are subject to change without notice. This may contain forward-looking statements and are not guarantees of performance. Reproduction of this without written permission is prohibited.

RealPennies.com

Phone: 212-662-2147

info [at] realpennies.com